GlassScriptPhysician profile
Jordan Bishop
NPI 1285358457
$1,161.83
in general payments reported to CMS, 2019-2025
12 companies · $1,104 in 2025
The $1,104 reported for 2025 was more than what 82% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $57.51 · 2025: $1,104.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,162.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,161.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $255.12 | 2025 | |
| Teva Pharmaceuticals USA, INC. | $180.89 | 2025 | Austedo Xr, Uzedy |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $168.27 | 2025 | Caplyta |
| Alkermes, INC. | $139.24 | 2025 | Aristada, Lybalvi, Vivitrol |
| Vanda Pharmaceuticals INC. | $91.93 | 2025 | Fanapt, Hetlioz |
| Neurocrine Biosciences, INC. | $87.08 | 2025 | |
| Otsuka America Pharmaceutical, INC. | $64.08 | 2024-2025 | Abilify Maintena, Abilify Asimtufii, Rexulti |
| Axsome Therapeutics, INC. | $59.28 | 2025 | Auvelity |
| Indivior INC. | $58.32 | 2024-2025 | Sublocade |
| E.R. Squibb & Sons, L.L.C. | $21.39 | 2025 | |
| Janssen Pharmaceuticals, INC | $18.47 | 2025 | Invega Sustenna, Invega Trinza |
| Vertex Pharmaceuticals Incorporated | $17.76 | 2025 | Journavx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jordan Bishop listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.